1. Grever MR, Schepartz SA, Chabner BA. The National Cancer Institute: cancer drug discovery and development program. Semin Oncol 1992; 19: 622–638.
2. Zubrod CG, Schepartz S, Leiter J, Endicott KM, Carrese LM, Baker CG. The chemotherapy program of the National Cancer Institute: history, analysis and plans. Cancer ChemotherRep 1966; 50: 349–540.
3. Goldin A, Schepartz SA, Venditti JM, DeVita VT Jr. Historical development and current strategy of the National Cancer Institute Drug Development Program. In: DeVita VT Jr, Busch H, eds. Methods in Cancer Research, vol XVI. New York: Academic, 1979: 165–245.
4. DeVita VT Jr, Goldin A, Oliverio VT, et al. The drug development and clinical trials programs of the Division of Cancer Treatment, National Cancer Institute. Cancer Clin Trials 1979; 2: 195–216.
5. Goldin A, Venditti JM. The new NCI screen and its implications for clinical evaluation. In: Carter SK, Sakurai Y, eds. Recent Results in Cancer Research, vol 70. Berlin: Springer-Verlag. 1980: 5–20.